Focus Stocks
Close to the 200 Day - Rowan Companies
Published on Wednesday, 08 February 2012 08:04 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Rowan Companies, Inc. (NYSE:RDC) traded at $36.60 close to its 200 day moving average currently set at $35.14. Rowan's price action is just above this key support level, and it will certainly raise traders attention, as a possible trading opportunity.
Rowan Companies, Inc. (NYSE:RDC) provides contract drilling services. The Company also owns and operates a manufacturing division that produces equipment for the drilling, mining and timber industries.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $33.72 and calculated resistance at $37.71. These levels will certainly be watched by traders, as they provide insight into the latest price dynamics defined by Rowan Companies stock.
Traders wanting to establish a position on Rowan Companies will be looking at the price action for evidence of buying near the 200 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- Approaching Support: Rowan Companies
- Is Rowan Companies Breaking Down?
- Trading Idea: Is Rowan Companies Breaking Down?
- Rowan Companies Is Near Important Moving Averages
- Rowan Reports First Quarter 2012 Operating Results
- Rowan Companies Is in a Well Defined Range
- Is Rowan Companies Breaking Out?
- Is Rowan Companies Expecting Resistance?
- Near Key Levels: Rowan Companies
- Is Rowan Companies Resistance Ahead?
Related Partner Headlines
- UPDATE: Deutsche Bank Reduces PT to $42, Reiterates Buy on Rowan Companies; One-Off Events Behind - Benzinga
- Rowan, Tenet: S&P Gainers - TheStreet.com
- Rowan: S&P Intraday Gainer - TheStreet.com
- UPDATE: Citi Raises Price Target on Rowan Companies to $37 - Benzinga
- Rowan Announces Proposed Change in Corporate Structure - Benzinga
- UPDATE: Rowan Q4 Profit Drops 21% - Benzinga
- Global Hunter Upgrades Rowan Companies to Buy - Benzinga
- Rowan Companies Stock Hits New 52-Week Low (RDC) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









